Polysaccharides: a targeting strategy for colonic drug delivery

Bibliography

• Patel M, Shah T, Amin A. Therapeutic opportunities in colon-specific drug-delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 2003;6(6):33-66
   PubMedGoogle Scholar
• Zhou HW. Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J Control Release 1994;29:239-52
   Web of Science ®Google Scholar
• Loftus EV, Silverstein MD, Sandborn WJ, Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000;46:336-43
   PubMed Web of Science ®Google Scholar
• Loftus EV, Silverstein MD, Sandborn WJ, Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-8
   PubMed Web of Science ®Google Scholar
• Edwards C. Physiology of the colorectal barrier. Adv Drug Deliv Rev 1997;28:173-90
   Web of Science ®Google Scholar
• Watts PJ, Illum L. Colonic drug delivery. Drug Dev Ind Pharm 1997;23(9):893-913
   Web of Science ®Google Scholar
• Rubinstein A. Approaches and opportunities in colon specific drug delivery. Crit Rev Ther Drug Carrier Syst 1995;12(2–3):101-49
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT. Targeting drugs to the colon: delivery systems for oral administration. J Drug Target 1994;2:241-58
   PubMed Web of Science ®Google Scholar
• Camma C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-73
   PubMed Web of Science ®Google Scholar
• Ewe K, Schwartz S, Petersen S, Press AG. Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease. Dig Dis Sci 1999;44:1434-9
   PubMed Web of Science ®Google Scholar
• Kaus LC, Fell JT, Sharma H, Taylor DC. On the intestinal transit of a single non-disintegrating object. Int J Pharm 1984;14:143-8
   Google Scholar
• Rubinstein A. Natural polysaccharides as targeting tools of drugs to the human colon. Drug Dev Res 2000;50:435-9
   Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15
   PubMed Web of Science ®Google Scholar
• Moore WEC, Holdeman LV. Discussion of current bacteriological investigations of the relationship between intestinal flora, diet and colon cancer. Cancer Res 1975;35:3418-20
   Web of Science ®Google Scholar
• Cummings JH, Englyst HN. Fermentation in the human large intestine and available substrates. Am J Clin Nutr 1987;45:1243-7
   PubMed Web of Science ®Google Scholar
• Levitt MD, Hirsh P, Fetzer CA, H2 excretion after ingestion of complex carbohydrates. Gastroenterology 1987;92:383-6
   PubMed Web of Science ®Google Scholar
• Van Soest PJ. Dietary fibers: their definition and nutritional properties. Am J Clin Nutr 1978;31:10S12-20
   Google Scholar
• Kinget R, Kalala W, Vervoort L, Mooter GU. Colonic drug targeting. J Drug Target 1998;6:129-49
   PubMed Web of Science ®Google Scholar
• Scheline RR. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Res 1973;25:451-523
   Google Scholar
• Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Medical J 2010;25:70-8
   Google Scholar
• Salyers AA. Energy sources of major intestinal fermentative anaerobes. Am J Clin Nutr 1979;32:158-63
   PubMed Web of Science ®Google Scholar
• Salyers AA, Brien M. Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacteriol 1980;143:772-80
   PubMed Web of Science ®Google Scholar
• Salyers AA, Vercellotti JR, West SHE, Wilkins TD. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol 1977;33:319-22
   PubMed Web of Science ®Google Scholar
• Rubinstein R, Radai M, Ezra S, In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm Res 1993;10:258-63
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT, Attwood D, Studies on pectin formulation for colonic drug delivery. J Control Release 1994;30:225-32
   Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Polysaccharides for colon targeted drug delivery. Drug Deliv 2004;11:129-48
   PubMed Web of Science ®Google Scholar
• Sriamornsak P. Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm 1998;169:213-20
   Web of Science ®Google Scholar
• Das S, Ka-Yun NG. Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation. J Pharm Sci 2010;99(12):4903-16
   PubMed Web of Science ®Google Scholar
• Bhalla HL, Shah AA. Controlled release matrices for ketoprofen. Ind Drugs 1991;28:420-2
   Google Scholar
• Brosio A, Dubaldo A, Verzegnassi B. Pulsed field gradient spin-echo NMR measurement of water diffusion coefficient in thickening and gelling agents: guar galactomannan solutions and pectin gels. Cell Mol Biol 1994;40:569-73
   PubMed Web of Science ®Google Scholar
• Gliko-Kabir I, Yagen B, Baluom M, Rubinstein A. Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the rat. J Control Release 2000;63(1-2):129-34
   PubMed Web of Science ®Google Scholar
• Payne GF, Chaubal MV, Barbari T. Enzyme-catalyzed polymer modification: reaction of phenolic compounds with chitosan films. Polymer (Guildf) 1996;37:4643-8
   Web of Science ®Google Scholar
• Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 1998;52:109-18
   PubMed Web of Science ®Google Scholar
• Risbud MV, Hardikar AA, Sujata V, pH sensitive freeze-dried chitosan–polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release 2000;68(1):23-30
   PubMed Web of Science ®Google Scholar
• Yassin AE, Dallia AR, Kassem AE. Comparative bioavailability of two tablet formulations of metronidazole in human volunteers: an assessment of colonic targeting. Egypt J Biomed Sci 2003;12:40–8
   Google Scholar
• Basit AW. Oral colon-specific drug delivery using amylose-based film coatings. Pharm Technol Eur 2000;12:30-6
   Google Scholar
• Ellis HS, Ring SG. A study of some factors influencing amylose gelation. Carbohydr Polym 1985;5:201-3
   Web of Science ®Google Scholar
• Roberfroid MB Introducing inulin-type fructans. Br J Nutr 2005;93(1):S13-25
   PubMed Web of Science ®Google Scholar
• McKellar RC, Modler HW Metabolism of fructooligosaccharides by Bifidobacterium spp. Appl Microbiol Biotechnol 1989;31:537-41
   Web of Science ®Google Scholar
• Vervoort L, Vinckier I, Moldenaers P, Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network. J Pharm Sci 1999;88(2):209-14
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001;224:19-38
   PubMed Web of Science ®Google Scholar
• Bauer KH, Kesselhut JF. Novel pharmaceutical excipients for colon targeting. STP Pharm Sci 1995;5:54-9
   Google Scholar
• Salyers AA, Vercellotti JR, West SHE, Wilkins TD. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol 1977;33:319-22
   PubMed Web of Science ®Google Scholar
• Rubinstein A, Nakar D, Sintov A. Chondroitin sulphate: a potential biodegradable carrier for colon-specific drug delivery. Int J Pharm 1992;84:141-50
   Web of Science ®Google Scholar
• Sintov A, Di-capua N, Rubinstein A. Cross-linked chondroitin sulphate: characterization for drug delivery purposes. Biomaterials 1995;16:473-8
   PubMed Web of Science ®Google Scholar
• Sery TW, Hehre EJ. Degradation of dextrans by enzymes of intestinal bacteria. J Bacteriol 1956;71:373-80
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ahmadi F, Emami J, Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat. Int J Prev Med 2010;1(2):116-24
   Google Scholar
• Bauer KH, Kesselhut JF. Novel pharmaceutical excipients for colon targeting. STP Pharm Sci 1995;5:54-9
   Google Scholar
• Hirsch S, Binder V, Kolter K, Lauroyldextran as a coating material for site-specific drug delivery to the colon: in-vitro dissolution of coated tablets. Proc Int Symp Control Rel Bioact Mater 1997;24:379-80
   Google Scholar
• Hirsch S, Binder V, Schehlmann V, Lauroyldextran and cross-linked galactomannan as coating materials for site-specific drug delivery to the colon. Eur J Pharm Biopharm 1999;47:61-71
   PubMed Web of Science ®Google Scholar
• Grant GT, Morris ER, Rees DA, Biological interactions between polysaccharides and divalent cations: the egg box model. FEBS Lett 1973;32:195-8
   Web of Science ®Google Scholar
• Pillay V, Danckwerts MP, Fassihi R. A crosslinked calcium-alginate-pectinate-cellulose acetophthalate gelisphere system for linear drug release. Drug Deliv 2002;9(2):77-86
   PubMed Web of Science ®Google Scholar
• Kim CK, Lee EJ. The controlled release of blue dextran from alginate beads. Int J Pharm 1992;79:11-19
   Web of Science ®Google Scholar
• Kulkarni AR, Soppimath KS, Aminabhavi TM, Dave AM. Polymeric sodium alginate interpenetrating network beads for the controlled release of chlorpyrifos. J Appl Polym Sci 2002;85(5):911-18
   Web of Science ®Google Scholar
• Xi MM, Zhang SQ, Wang XY, Study on the characteristics of pectin-ketoprofen for colon targeting in rats. Int J Pharm 2005;298(1):91-7
   PubMed Web of Science ®Google Scholar
• Van den MG, Vervoort L, Kinget R. Characterization of methacrylated inulin hydrogels designed for colon targeting: in vitro release of BSA. Pharm Res 2003;20(2):303-7
   PubMed Web of Science ®Google Scholar
• Maris B, Verheyden L, Van Reeth K, Synthesis and characterization of inulin-azo hydrogels designed for colon targeting. Int J Pharm 2001;213(1-2):143-52
   PubMedGoogle Scholar
• Larsen C, Jensen BH, Olesen HP. Bioavailability of ketoprofen from orally administered ketoprofen–dextran ester prodrug in the pig. Acta Pharm Nord 1991;3:71-6
   PubMedGoogle Scholar
• Harboe E, Larsen C, Johansen M, Olesen HP. Macromolecular prodrugs. XV. Colon targeted delivery – bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Pharm Res 1989;6:919-23
   PubMed Web of Science ®Google Scholar
• McLeod AD, Friend DR, Tozer TN. Glucocorticoid–dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J Pharm Sci 1994;83:1284-8
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Fassihi A, Effectiveness of budesonide-succinate- dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int J Colorectal Dis 2010;25:1159-65
   PubMed Web of Science ®Google Scholar
• Tozaki H, Fujita T, Odoriba T, Colon, a specific delivery of R68070 new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid induced ulcerative colitis in rats. Life Sci 1999;64:1155-62
   PubMed Web of Science ®Google Scholar
• Tozaki H, Odoriba T, Okada N, Chitosan capsules for colonspecific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release 2002;82:51-61
   PubMed Web of Science ®Google Scholar
• Tozaki H, Komoike J, Tada C, Chitosan capsules for colonspecific drug delivery: Improvement of insulin absorption from rat colon. J Pharm Sci 1997;86:1016-21
   PubMed Web of Science ®Google Scholar
• Brondsted H, Andersen C, Hovgaard L. Cross-linked dextran – a new capsule material for colon targeting of drug. J Control Release 1998;53:7-13
   PubMed Web of Science ®Google Scholar
• Tuleu C, Basit AW, Waddington WA, Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules. Aliment Pharmacol Ther 2002;16(10):1771-9
   PubMed Web of Science ®Google Scholar
• Rama Prasad YV, Krishnaiah YS, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Release 1998;51:281-7
   PubMed Web of Science ®Google Scholar
• Al-Saidan SM, Krishnaiah YS, Satyanarayana V, Rao GS. In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery. Curr Drug Deliv 2005;2(2):155-63
   PubMedGoogle Scholar
• Krishnaiah YS, Satyanarayana V, Kumar BD, Karthikeyan RS. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer. J Drug Target 2002;10(3):247-54
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Veer Raju P, Dinesh Kumar B, Development of colon targeted drug delivery systems for mebendazole. J Control Release 2001;9:77(1-2):87-95
   Google Scholar
• Raghavan CV, Muthulingam C, Jenita JA, Ravi TK. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem Pharm Bull 2002;50(7):892-5
   PubMed Web of Science ®Google Scholar
• Wakerly Z, Fell JT, Attwood D, Parkins D. Pectin/Ethyl cellulose film coating formualtions for colonic drug delivery. Pharm Res 1996;13(8):1210-12
   PubMed Web of Science ®Google Scholar
• Wei H, Qing D, De-Ying C, Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. PDA J Pharm Sci Technol 2007;61(2):121-30
   PubMedGoogle Scholar
• Wei H, Li-Fang F, Yong-Zhen C, Pectin/Kollicoat SR30D isolated films for colonic delivery: a comparison of normal and colitis-induced models to assess the efficiency of microbially triggered drug delivery. J Pharm Pharmacol 2009;61(2):167-76
   PubMed Web of Science ®Google Scholar
• Ji CM, Xu HN, Sun NY, Guar gum/ethylcellulose coated pellets for colon-specific drug delivery. Acta pharmaceutica Sinica 2007;42(6):656-62
   PubMedGoogle Scholar
• Leong CW, Newton JM, Basit AW, The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37°C. Eur J Pharm Biopharm 2002;54:291-7
   PubMed Web of Science ®Google Scholar
• Wilson PJ, Basit AW. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets. Int J Pharm 2005;300(1-2):89-94
   PubMedGoogle Scholar
• Milojevic S, Newton JM, Cummings JH, Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J Control Release 1996;38:75-84
   Web of Science ®Google Scholar
• Milojevic S, Newton JM, Cummings JH, Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J Control Release 1996;38:85-94
   Web of Science ®Google Scholar
• Semde R, Amighi K, Devleeschouwer MJ, Moes AJ. Studies of pectin HM: Eudragit RL:Eudragit NE film-coating formulations intended for colonic drug delivery. Int J Pharm 2000;197:181-92
   PubMed Web of Science ®Google Scholar
• Macleod GS, Fell JT, Collett JH, Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets. Int J Pharm 1999;187:251-7
   PubMed Web of Science ®Google Scholar
• Tominaga S, Takaizawa T, Yamada M. Colon drug delivery system. J Pol Appl 1998;JP 10: 642 (98324,642) (C1 A61K47/36)
   Google Scholar
• Rubinstein A, Radai R. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Biopharm 1995;41:291-5
   Web of Science ®Google Scholar
• Patel NV, Patel JK, Shah SH. Box-Behnken. Experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. Acta Pharm 2010;60:39–54
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Indira Muzib Y, Srinivasa Rao G, Design and in vitro evaluation of oral colon targeted drug delivery systems for tinidazole. J Drug Target 2002;Dec;10(8):579-84
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Muzib YI, Rao GS, Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis. Drug Deliv 2003;10(2):111-17
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci 2002;16(3):185-92
   PubMed Web of Science ®Google Scholar
• Nunthanid J, Huanbutta K, Luangtana-anan M, Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose. Eur J Pharm Biopharm 2008;68:253-9
   PubMed Web of Science ®Google Scholar
• Alaa-Eldeen BY, Ibrahim AA, Fars KA, New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging. J Drug Target 2010;18(1):59-66
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target 2007;15(4):285-94
   PubMed Web of Science ®Google Scholar
• Paharia A, Yadav AK, Rai G, Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSci Tech 2007;8(1):E1-7
   PubMedGoogle Scholar
• Vaidya A, Jain A, Khare P, Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci 2009;98(11):4229-36
   PubMed Web of Science ®Google Scholar
• Jain SK, Jain A, Gupta Y, Ahirwar M. Design and development of hydrogel beads for targeted drug delivery to the colon. AAPS PharmSci Tech 2007;8(3):E1-8
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 2004;11:201-7
   PubMed Web of Science ®Google Scholar
• Jose S, Dhanya K, Cinu TA, Aleykutty NA. Multiparticulate system for colon targeted delivery of Ondansetron. Ind J Pharm Sci 2010;72(1):58-64
   PubMed Web of Science ®Google Scholar
• Liu H, Yang XG, Nie SF, Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. Int J Pharm 2007;332(1-2):115-24
   PubMed Web of Science ®Google Scholar
• Pitarresi G, Casadei MA, Mandracchia D, Photo crosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery. J Control Release 2007;119:328-38
   PubMed Web of Science ®Google Scholar